During the past decade, Woodlands Medical Specialists conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 12 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 6 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Woodlands Medical Specialists" #1 sponsor was "SCRI Development Innovations, LLC" with 8 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "GRAIL, LLC" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Woodlands Medical Specialists" #1 collaborator was "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "GlaxoSmithKline" with 3 trials as a collaborator, "Novartis" with 3 trials as a collaborator, "Cephalon" with 1 trials as a collaborator and "Chugai" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Woodlands Medical Specialists" are "Cancer" (3 trials), "Metastatic Breast Cancer" (3 trials), "Advanced Cancer" (2 trials), "Multiple Myeloma" (2 trials) and "Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Woodlands Medical Specialists" in a lesser frequency.

Most popular intervention types in "Woodlands Medical Specialists" are "Drug" (33 trials), "Biological" (4 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (7 trials), "Placebo" (6 trials), "Atezolizumab" (4 trials), "Cisplatin" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Woodlands Medical Specialists" are 35 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Woodlands Medical Specialists". undefined are not yet recruiting, 9 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Woodlands Medical Specialists, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Woodlands Medical Specialists, 4 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".